share_log

巴克莱:维持Neurocrine Biosciences(NBIX.US)评级,由增持调整至增持评级, 目标价由150.00美元调整至169.00美元。

Zhitong Finance ·  May 2 14:05

巴克莱:维持Neurocrine Biosciences(NBIX.US)评级,由增持调整至增持评级, 目标价由150.00美元调整至169.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment